
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66621
Endocrinology/Diabetes/Metabolism
Dentistry
Healthcare Technology
Macrophage-Centric Biomaterials for Bone Regeneration in Diabetes Mellitus: Contemporary Advancements, Challenges, and Future Trajectories
Muacevic Alexander
Adler John R
Yang Yiyan 1
He Xiaoli 1
Zhao Zhihe 1
Yi Jianru 1
1 Department of Orthodontics, State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, CHN
Jianru Yi jianruyi@scu.edu.cn
11 8 2024
8 2024
16 8 e666219 8 2024
Copyright © 2024, Yang et al.
2024
Yang et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/264204-macrophage-centric-biomaterials-for-bone-regeneration-in-diabetes-mellitus-contemporary-advancements-challenges-and-future-trajectories
Increased susceptibility to bone fragility and the diminution of bone regenerative capacity are recognized as significant and frequent sequelae of diabetes mellitus. Research has elucidated the pivotal role of macrophages in the pathogenesis and repair of diabetic bone defects. Notwithstanding this, the therapeutic efficacy of traditional interventions remains predominantly inadequate. Concomitant with substantial advancements in tissue engineering in recent epochs, there has been an escalation in the development of biomaterials designed to modulate macrophage activity, thereby augmenting osseous tissue regeneration in the context of hyperglycemia. This review amalgamates insights from extant research and delineates recent progressions in the domain of biomaterials that target macrophages for the regeneration of diabetic bone, whilst also addressing the clinical challenges and envisaging future directions within this field.

osteogenesis
biomaterials
bone regeneration
macrophage
diabetes mellitus
==== Body
pmcIntroduction and background

Diabetes mellitus is a metabolic disease characterized by hyperglycemia and chronic inflammation. As of 2021, the prevalence of diabetes mellitus has reached 536.6 million worldwide, with an estimated increase to 783.2 million in 2045 [1]. The persistent hyperglycemic state and chronic inflammatory response contribute to a spectrum of complications, including cardiovascular diseases, nerve damage, chronic kidney diseases, and bone disorders, imposing a substantial burden on healthcare systems and patients [2,3].

Among the complications, diabetic bone diseases have garnered considerable attention. These maladies conditions manifest as reduced bone density, long-term nonunion of bone defects, and alterations in bone microstructure [4,5]. The underlying mechanisms are multifaceted, involving impaired osteogenic capacity, heightened osteoclastic activity, and unremitting inflammatory processes [6]. Prolonged hyperglycemia inhibits the migration and proliferation of bone marrow mesenchymal stem cells (BMSCs), diverting them toward adipogenic lineage rather than osteogenic lineage, and promoting BMSC senescence and apoptosis [7]. Moreover, the dysregulation of osteoblasts and osteoclasts due to hyperglycemia disrupts bone homeostasis [8]. The high glucose environment further destabilizes immune equilibrium, culminating in chronic inflammation that impedes bone repair processes [5]. Additionally, the hyperglycemic microenvironment at injury sites exacerbates susceptibility to bacterial infections, further complicating the therapeutic landscape of diabetic osteopathy [9].

Macrophages, a subset of leukocytes, actively participate in both innate and adaptive immunity. These versatile immune cells are instrumental in orchestrating inflammation and bone remodeling during reparative phenomena. Nonetheless, diabetes mellitus precipitates aberrant macrophage activation, engendering exacerbated inflammatory reactions that hinder osteogenic repair mechanisms [10]. Indeed, several studies have underscored that strategic modulation of macrophage functionality can significantly ameliorate bone defect rectification under hyperglycemic conditions [11-13]. Hence, macrophage immunomodulation has been identified as a salient therapeutic avenue for the enhancement of diabetic bone repair [14].

The preceding decades have witnessed substantial evolution and integration of biomaterials in the realm of bone regeneration, attributable to their advantageous physicochemical attributes [15]. These materials eclipse conventional therapeutic modalities by precise targeting capabilities, minimized dosing requirements, and attenuated adverse effects [15]. Recognizing the pivotal role of macrophages in diabetic bone diseases, burgeoning research endeavors have concentrated on the synthesis of biomaterials that engage macrophages to expedite bone restoration in the diabetic context [16]. This review endeavors to encapsulate the contemporary advancements in macrophage-centric biomaterials for diabetic bone regeneration, whilst concurrently contemplating the challenges inherent in their application and projecting prospective trajectories in this burgeoning field.

Review

This review employed a comprehensive search approach to identify all relevant articles published in multiple databases including PubMed, Scopus, Science Direct, and Web of Science, using the keywords “biomaterials”, “macrophages”, “bone regeneration”, and “diabetes”. To enhance the search, the most frequently used phrases in publications on this topic were combined with Medical Subject Headings (MeSH) terms. Inclusion criteria were: (i) biomaterials that relate to macrophages, and (ii) designed for bone regeneration in diabetes mellitus. All irrelevant articles were excluded. Manual searches were also performed by cross-checking the references of the included literature to identify potentially overlooked publications during the electronic search.

The critical role of macrophages in diabetic bone regeneration

Macrophages in Normal Bone Regeneration

Macrophages are dichotomously categorized into two principal phenotypes: the pro-inflammatory M1 and the anti-inflammatory M2 [17]. M1 macrophages are characterized by their secretion of inflammatory cytokines including tumor necrosis factor-alpha (TNF-α), Interleukin (IL)-1β, IL-6, and inducible nitric oxide synthase (iNOS), which, upon sustained exposure, can precipitate immunopathological responses and consequent tissue detriment [18]. Conversely, M2 macrophages are distinguished by their release of anti-inflammatory agents like IL-10 and TGF-β1, which are vital for stem cell viability during tissue repair [19].

In the context of bone homeostasis, macrophages are pivotal, executing phagocytosis and cytokine production [20]. They modulate inflammatory reactions, osteogenesis, and osteoclastogenesis throughout the bone regeneration process [21], with behaviors varying dynamically at different stages of bone repair due to the highly dynamic extracellular microenvironment [22]. During the initial inflammation phase, immune cells rapidly migrate to sites of bone injury. Here, inflammatory mediators stimulate monocytes and resident macrophages to differentiate into the M1 phenotype [22]. Concurrently, the hematoma surrounding the injury fosters a hypoxic, acidic environment conducive to M2 polarization and the osteogenic and chondrogenic differentiation of bone marrow mesenchymal stromal cells (BMSCs) [23,24]. Typically, a phenotypic shift from M1 to M2 occurs within three to four days after injury, whereas persistent M1 activation can lead to prolonged inflammation at the injury site, ultimately impeding bone healing [25]. In the subsequent primary callus stage, BMSCs differentiate into fibroblasts, chondroblasts, and osteoblasts, facilitated by M2-derived cytokines like IL-4 and IL-10. Simultaneously, M1-produced cytokines such as IL-6 and TNF-α instigate angiogenesis by promoting endothelial cell migration and proliferation [26,27]. As the macrophage phenotype transitions towards M2, anti-inflammatory cytokine expression increases, consolidating angiogenesis and orchestrating extracellular matrix (ECM) assembly through pericyte recruitment and differentiation [28].

In the final stage, the callus is progressively replaced by new bone tissue, necessitating a delicate equilibrium between bone formation and resorption, orchestrated by macrophages [29]. M1 macrophages impede BMSC osteogenic differentiation via MAPK pathways [30], and impede ECM secretion and mineralization through IL-1β and TNF-α [31]. Simultaneously, M1 macrophages promote osteoclastogenesis by activating JAK2 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathways through IL-6 and TNF-α, respectively [32,33]. Conversely, M2 macrophages inhibit early-stage osteoclastogenesis by interfering with NF-κB binding, and contribute to osteogenesis [34,35]. In return, skeletal stem cells mitigate M1 macrophage functions and promote the production of anti-inflammatory cytokines such as IL-10 from M2 macrophages by releasing prostaglandin E2 [36,37].

Collectively, M1 macrophages are instrumental in the initial phase of bone repair, promoting regeneration, while the M2 phenotype gains prominence in subsequent stages. The intricate and harmonious interplay among macrophages, osteoblasts, and osteoclasts ensures the successful restoration of normal bone tissue structure and function.

Macrophage in Diabetic Bone Regeneration and Targeting Strategies

Macrophages, owing to their remarkable phenotypic plasticity, exhibit adaptability to diverse stimuli within the bone microenvironment, resulting in distinct functional polarization. These phenotypic and functional shifts in macrophages are significant in diabetic bone metabolism [38]. Hyperglycemic conditions induce a metabolic pivot towards glycolysis in monocytes and macrophages, leading to an increase in reactive oxygen species (ROS) production [39]. ROS serves as a critical mediator for pro-inflammatory pathway activation and can instigate M1 polarization through epigenetic reprogramming [39]. An imbalanced M1/M2 macrophage ratio disrupts osteogenesis and promotes osteoclastogenesis, thereby impeding bone regeneration in hyperglycemic states. Additionally, heightened glucose levels enhance the expression of the glucose transporter type 1 sensor in macrophages, potentially inducing macrophage senescence. The accumulation of senescent cells and their associated secretory phenotype further exacerbates inflammatory bone loss in diabetes [40].

In light of their integral role in diabetic bone regeneration, macrophages have been identified as a promising therapeutic target to improve repair efficacy. Presently, two primary macrophage-centric strategies are being explored. The first involves modulating macrophage phenotypes at defect sites, with a focus on fostering M2 polarization and transitioning M1 macrophages towards an M2 phenotype [16], as such transitioning macrophages exhibit superior regenerative capabilities compared to those directly polarized to M2 from inactive monocytes [41]. However, M1 macrophages are essential for angiogenesis, and excessive M2 activation may result in fibrosis and pathological osteogenesis due to fibroblast cytokine secretion [36,42]. Thus, a strategic approach is required for the sequential activation of M1 and M2 phenotypes and the regulation of their ratio, as excessive inhibition of M1 macrophages in the early stage or insufficient activation of M2 macrophages in the later phase can compromise bone regeneration [43]. The second strategy aims to bolster the macrophage population at defect sites to counteract hyperglycemia-induced macrophage senescence and apoptosis. It has been proved that bone regeneration can be enhanced by augmenting the macrophage population through local injection of macrophage colony-stimulating factor (M-CSF) at fracture sites [44,45]. Furthermore, direct delivery of monocytes or pre-polarized macrophages to injury areas has also shown favorable effects [21].

Macrophage-related biomaterials for diabetes mellitus

Although conventional therapeutic methods demonstrate efficacy under physiological conditions, they fall short of achieving satisfactory outcomes for diabetic bone defects. This limitation arises due to the complicated microenvironment in diabetes mellitus and altered macrophage niches [14]. Biomaterial-based therapies offer a promising avenue for enhancing bone reconstruction in diabetes. They have the potential to address two major challenges faced by traditional strategies: the lack of control over the maintenance of macrophage phenotype, and the limited retention of macrophages at injury sites [46].

Metal and Metal Alloy Biomaterials

Metals and metal alloys find extensive use in load-bearing bone applications owing to their remarkable strength and stiffness. Titanium (Ti) and its alloys are particularly prevalent in bone repair implants [47,48]. Surface modifications at the nanoscale and functional coatings enhance the regulatory effects of Ti-based materials on macrophages. For instance, coating Ti-based scaffolds with piezoelectric Barium Titanate promoted anti-inflammatory polarization of macrophages and improved bone repair efficacy [49]. Similarly, aspirin/poly(lactic-co-glycolic acid) (PLGA)-coated Ti-based substrates exhibited enhanced M2 protein expression, reduced M1 protein expression, and greater osteogenic potential both in vitro and in vivo [50].

Natural Polymers

Macrophage-targeting natural polymers primarily originate from the ECM and other biological sources. These polymers offer inherent biocompatibility and anti-inflammatory effects, leading to the development of preclinically applicable biomaterials with optimized physicochemical properties [51]. Decellularized ECM scaffolds, which maintain native ECM components and structure [16], significantly encourage M2 polarization, fostering an immune-supportive environment [52]. This effect may be attributed to the rheological properties and protein components of the scaffold [52]. It’s also noteworthy that thorough decellularization is crucial, as cellular remnants and mitochondria can trigger pro-inflammatory responses [53]. Due to the immunogenic blocks of β-D-mannuronic acid, alginate is capable of regulating macrophage phenotypes, cytokine release, and phagocytosis through increasing Toll-like receptor 4 expression and activating the NF-κB and p38 mitogen-activated protein kinase (MAPK) signaling pathways [54,55]. Sulfated alginate, in particular, promotes M2-like polarization of human THP-1 monocytes and reduces pro-inflammatory cytokine production [56]. Polyguluronate liposomes fabricated using α-L-guluronic acid derived from alginate have been also confirmed to enhance macrophage-stimulating activity [57].

Hydrogel scaffolds made from natural polymers have also been explored. A novel scaffold enriched with platelet lysate demonstrated sustained bioactive component release, promoting M2 macrophage migration and polarization, and thereby increasing anti-inflammatory cytokine production [58]. Furthermore, scaffolds incorporating vesicles from red blood cell membranes have been shown to attract M2 macrophages, maintaining their presence for one month post injection [59].

Synthetic Polymers

Synthetic polymers represent a class of intentionally designed biomaterials with diverse structures and customized properties. Notable examples include polylactic acid (PLA), polyglycolic acid (PGA), PLGA, and polycaprolactone (PCL) [60]. In the context of bone regeneration, synthetic polymers are frequently employed to construct scaffolds, serving as structural support for defect areas and platforms for localized drug delivery [61].

Recent advancements have seen the development of polymers that can influence macrophage activity. For instance, a particular copolymer, poly(octanediol-citrate-polyglycol) (POCG), has demonstrated the ability to suppress proinflammatory cytokine expression and polarize macrophages toward the M2 phenotype [62]. Additionally, polymeric electrospun fibers have also exhibited immunomodulatory effects on macrophages, leading to high-quality bone regeneration in both in vitro and in vivo experiments [63].

Composite Biomaterials

Given the intricate and hierarchical structure of human bones, a single biomaterial may fall short of meeting the requirements for effective bone structure and function restoration. Consequently, efforts have been directed toward developing composite biomaterials that integrate multiple components. A common strategy involves combining polymers with inorganic materials to create scaffolds [64]. Inorganic particles such as silica nanoparticles and bioceramic nanoparticles can serve as drug delivery carriers to modulate macrophage behavior [65,66]. Another method involves the use of metal-organic frameworks (MOFs), which exhibit high specific surface areas and tuneable pore structures, enabling efficient capture, transport, and release of regulatory agents [67]. These properties make MOFs promising candidates for regulating macrophage functions and promoting bone repair.

Recent research progress

With the development of biomaterials, intelligent responsive biomaterials that are capable of sensing microenvironment changes, particularly glucose levels, have emerged as a focal point in diabetic bone regeneration [68]. Li et al. engineered a hydrogel with a dual-logic response mechanism, composed of reversibly cross-linked poly(vinyl alcohol) and a colloidal network formed from gelatin nanoparticles [69]. This hydrogel demonstrated the capacity for intelligent modulation of drug release contingent upon glucose, ROS, and matrix metalloproteinase levels, thereby facilitating macrophage polarization and enhancing bone repair under diabetic conditions. Wang et al. developed a glucose-sensitive system capable of delivering anti-TNF-α antibodies through a quaternized chitosan and collagen scaffold [70]. This system mitigates M1-related local inflammation under long-term hyperglycemic conditions. Furthermore, Zheng et al. constructed a pH-responsive nanoplatform comprising an IL-4-loaded gallic acid-magnesium-based MOF core and a biodegradable calcium phosphate shell [71]. When integrated into collagen scaffolds, this nanoplatform effectively safeguarded bioactive factors, exhibiting controlled degradation in response to acidic conditions, thereby fostering M2 macrophage polarization.

Furthermore, Kang et al. introduced an innovative magnetic-controlled system for remote manipulation of macrophage behavior [72]. By conjugating Arg-Gly-Asp (RGD)-grafted gold nanoparticles (GNPs) to a glass substrate and pairing them with magnetic nanocages via a flexible linker, they created a heterodimeric nanostructure. This configuration allowed for the precise control of RGD exposure, enhancing macrophage adhesion and M2 polarization through rho-associated protein kinase signaling pathways, while simultaneously suppressing M1 polarization, both in vitro and in vivo.

Three-dimensional (3D) bioprinting holds immense promise for constructing precisely controlled structures with tailored mechanical and biological properties [61]. Unlike other technologies, it enables the simultaneous fabrication of structures composed of biomaterials and cells [61]. The key component in 3D bioprinting is the bioink, which encompasses cell-loaded hydrogels, decellularized ECM-based solutions, and cell suspensions [73]. Sun et al. demonstrated the efficacy of a 3D bioprinted scaffold using a modified bioink containing gelatin, gelatin methacryloyl, and four-arm poly(ethylene) glycol (PEG) acrylate [74]. Loaded with BMSCs, RAW264.7 macrophages, and mesoporous silica nanoparticles carrying BMP-4, this scaffold significantly promoted M2 polarization and osteogenic differentiation of BMSCs upon implantation in a diabetic mellitus context. The latest biomaterials targeting macrophages for bone regeneration in diabetes are described in Table 1.

Table 1 The latest progress in biomaterials targeting macrophages for bone regeneration in diabetes

TNF-α: tumor necrosis factor-alpha; IL: interleukin; Mg: magnesium; Ca: calcium; ROS: reactive oxygen species; MMP: matrix metalloproteinases; BMP2: Bone morphogenetic protein-2; RGD: arginine–glycine–aspartic acid; GelMA: gelatin methacrylate; PEG: poly(ethylene glycol); MSN: mesoporous silica nanoparticle; BMSC: bone marrow mesenchymal stromal cell

Biomaterials	Functional characteristics	Effects on macrophages	Advantages	Disadvantages	
Glucose-sensitive  scaffolds  	Accelerated delivery rate of TNF-α antibody with the increase of glucose concentration.	Inhibiting M1 polarization.	1. Improved efficiency of drug release. 2. Honeycombed structure with pore shape and porosity suitable for bone regeneration.	The drug content of the system still needed to be improved.	
pH-responsive nanoplatforms	Slowly degrading and releasing gallic acid, IL-4, Mg2+, and Ca2+ ions with the decrease of pH.	Enhancing M2 polarization.	1. Protecting bioactive factors loaded inside. 2. Moderate and sustained delivery rate.	The surface of nanoplatform hybrid scaffold was uneven.	
Dual-logic-based system	Responding to the level of glucose, ROS, and MMPs, and determining the release time and types of specific cargos (IL-10 and BMP-2).	Regulating macrophage polarization by remodeling the mitochondria-related antioxidative system.	1. Possessing both diagnostic and basic therapeutic logic. 2. Accurately regulating IL-10 and BMP-2 delivery to match the period of macrophage polarization.  	Not effective enough in severe diabetes with high glucose fluctuation.  	
Magnetic-controlled system	Magnetically manipulating nanoscale displacement of magnetic nanocage to reversibly uncage or cage RGD.  	Promoting the adhesion and M2 polarization, and inhibiting M1 polarization.	1. Working as a single magnetic domain to promote osteogenesis without an external magnetic field stimulus. 2. Achieving the remote and reversible manipulation on the uncaging of RGD.	The system was not stable enough and likely to be interfered with by the external magnetic fields.  	
3D bio-printed  scaffolds 	1. Constructed by highly biocompatible GelMA/gelatin/PEG/MSN composite bioinks and loaded with BMSCs, macrophages, and mesoporous silica nanoparticles carrying BMP-4. 2. The sustained release of BMP-4 with the biodegradation of materials.	Promoting M2 polarization.	1. Precisely controlled shapes and structures. 2. Personalized mechanical and biological properties. 3. Containing biomaterials and cells simultaneously	Manufacturing processes placed high requirements on instruments.	

Design strategies and functional mechanisms of macrophage-related biomaterials

The interaction of macrophages with these implanted materials is a complex and dynamic process. It initiates with the host’s primary immune response, marked by the sequential activation of M1 and M2 macrophage phenotypes [75]. The biomaterials subsequently assume a pivotal role in directing the functional transitions or stabilization within the macrophage contingent to establish the anti-inflammatory and pro-regenerative microenvironment. The bioactive molecules and pharmacological agents liberated from the biomaterials can directly govern the phenotypic and functional directives of macrophages, and the physicochemical properties of the biomaterials influence macrophage behaviors, including adherence, phagocytosis, plasticity, and apoptosis. In due course, these materials are subject to either complete or partial biodegradation via macrophage phagocytosis and/or degradation mediators released from foreign body giant cells (FBGCs) [76].

Biomaterials as Macrophage-Regulatory Delivery Systems

The use of biomaterial-based local delivery systems remains to be the forefront of bone regeneration strategies. These systems are designed to control the release of regulatory molecules, encompassing cytokines, pharmaceuticals, nucleic acids, and proteins. Some strategies are specifically tailored to administer pre-polarized macrophages or BMSCs directly [14,16].

One notable example is the localized administration of IL-4 to augment bone repair by upregulating the M2 macrophage phenotype in a dose-dependent manner [77]. Notably, biomaterial-based strategies guarantee a mild yet sustained release of IL-4, as well as avoiding the prolonged M1 phenotype phase caused by over-elevated doses of IL-4 [78]. The nanofibrous heparin-modified gelatin microsphere can improve IL-4 stabilization and prolong IL-4 release to modulate macrophage polarization from M1 to M2 phenotype, promoting bone regeneration in diabetes mellitus [79]. Similarly, the gelatin/β-tricalcium phosphate scaffold with sustained release of IL-4 to induce M2 polarization enhanced tooth extraction socket healing in diabetes [80]. Moreover, the local and sustained release of IL-10 has also been achieved in several biomaterial-based strategies, such as the physically crosslinked DNA hydrogel and the injectable self-assembling peptide hydrogel, which effectively promote the transition from M1 to M2 phenotype and diabetic bone reconstruction [81,82]. Beyond IL-4 and IL-10, other members of the TGF superfamily, such as TGF-β3, BMP-2, and BMP-4, are involved in regulating macrophages for bone regeneration in diabetes as well, making them potential targets in future research on biomaterial-based therapy [83,84].

Owing to their distinctive impact on macrophage behavior and function, metal ions have been critical elements in the design of biomaterials for bone repair in diabetes [85]. For instance, the prolonged and gradual release of Mg2+ ions from HA/MgO nanocrystal-based hybrid hydrogels markedly enhances bone regeneration related to diabetes by downregulating M1 macrophage infiltration and hastening the secretion of osteoblast-inducing factors like BMP-2 and IL-1RA from macrophages [86]. In addition, the local administration of specific pharmaceuticals constitutes an efficacious strategy. Sitagliptin, commonly prescribed for type 2 diabetes, promotes M2 polarization, curtails M1 phenotype stimulation, and diminishes IL-1β, TNF-α, and IL-6 secretion induced by lipopolysaccharide (LPS), thereby enhancing bone healing in diabetic patients [87-89]. Sitagliptin also reduces the mRNA expression of iNOS, IL-12 p35, and IL-12 p40 in macrophages, forestalling the escalation of inflammatory responses and subsequent tissue damage [89].

More recently, there has been the development of biomaterials that are specifically designed to sequentially release disparate regulatory molecules to govern macrophage recruitment and M1/M2 states at various stages [43]. The most prevalent approach involves the initial release of interferon-gamma (IFN-γ) to induce the M1 phenotype, followed by the subsequent delivery of IL-4/13 to effectuate M2 polarization [43,90]. To ensure adequate macrophage infiltration, MCP-1 is incorporated for release during the early inflammatory phase [91]. However, most extant sequential delivery systems have yet to achieve a clear demarcation between the two release phases, potentially inducing mixed phenotypes and disrupting the functionality of various cells [43]. There is an ongoing need to develop more sophisticated methodologies to precisely control the timing and dosage of release.

Due to the complex and changeable microenvironment, the hindered recruitment of monocytes to defect sites, and the dysfunctional polarization due to epigenetic alterations in diabetes, strategies that solely depend on the patient’s endogenous macrophages may fail to achieve optimal therapeutic results [92]. Hence, biomaterials that are devoted to directly delivering pre-polarized M2 macrophages or BMSCs to defect sites emerge as a promising approach, particularly for the elderly demographic [46]. Nonetheless, this strategy necessitates further exploration regarding its safety and feasibility. Figure 1 shows the common types of macrophage-related biomaterials and their functional mechanism.

Figure 1 Macrophage-related biomaterials for diabetic bone regeneration

(a) Common types of macrophage-related biomaterials; (b) Functional mechanism of macrophage-related biomaterials. Macrophage-related biomaterials are designed to achieve sequential activation and maintenance of M1 and M2 phenotypes, enhance M2/M1 ratio by promoting M2 macrophage polarization, and increase macrophage retention at defect sites, thereby enhancing bone regeneration in hyperglycemia.

Image Source: Authors

Biophysical Properties of Biomaterials With Regard to Macrophages

Macrophages exhibit sensitivity to the biomechanical alterations in substrate stiffness, which can manifest in variations in their morphological structure, migratory patterns, polarization, and functional capacities [16,93]. Presently, no consensus regarding the optimal stiffness parameters of various biomaterials for governing phenotypes has been reached. Some studies reported that an escalation in stiffness favors M1 polarization [93], while others have demonstrated contrary outcomes [94,95].

The topographical attributes of biomaterials are also critical determinants. Surfaces with greater roughness have been shown to exert a pronounced anti-inflammatory influence on macrophages [96], and microscale crumpled topographies have been significantly associated with an increase in M2 polarization, as opposed to nano- and submicroscale structures [97]. Intriguingly, surfaces with lower roughness at the nanoscale also promote M2 polarization and the release of anti-inflammatory cytokines [98]. The material surface patterns are also crucial. Micro-stripe patterned substrates are inclined to foster an M2 phenotype, with grooves guiding macrophages to align along the pattern direction, thereby enhancing IL-10 secretion and diminishing TNF-α expression [99,100].

Additional factors influencing macrophage behavior include the dimensions and geometry of pores and particles, porosity, particle concentration, and molecular weight of biomaterials. The enlarged pore sizes and higher porosity tend to induce a rounded macrophage morphology and favor M2 polarization [101,102]. Nano-sized particles, in comparison to micro-sized ones, significantly elevate the population of M2 macrophages and reduce the expression of inflammatory genes [103,104]. Within the nanometer scale, larger particle sizes may further enhance M2 polarization [105,106]. Spherical particles demonstrate a superior rate of phagocytosis and are more conducive to M2 polarization, relative to other geometries such as needles, rods, and worm-like forms [107-109]. Moreover, an increase in particle concentration has been found to induce an M1 phenotype, leading to oxidative stress and apoptosis [110]. Lower molecular weights tend to incite an M1 phenotype, whereas higher molecular weights are associated with M2 polarization [111].

Biochemical Properties of Biomaterials With Regard to Macrophages

Distinct functional groups within biomaterials have been empirically established to elicit specific responses in macrophages. Instructive consideration includes the involvement of the oxygen functional groups for greater macrophage adhesion and activation [112], and the introduction of amine to exert a pronounced anti-inflammatory effect on LPS-activated macrophages through the upregulation of autophagy pathway constituents [113,114]. Moreover, the catechol moieties group on biomaterial exhibits exceptional ROS scavenging capabilities, which significantly bolster the secretion of osteogenesis-related cytokines by M2 macrophages and inhibit M1 macrophage activity, thus expediting the healing of diabetic periodontal bone lesions [115].

In the context of osseous regeneration, the piezoelectric response and bioelectric transduction at the site of repair are imperative [116,117]. The localized reinstatement and conveyance of electrical signals are known to modulate the M2/M1 macrophage ratio under diabetic conditions [118]. Biomaterial surfaces with a positive charge are conducive to M2 polarization, while those with negative or neutral charges are inclined to induce an M1 phenotype [118,119]. Piezoelectric materials are capable of mimicking the electrical microenvironment, thereby inhibiting M1 polarization prompted by elevated glucose levels and facilitating the transition of macrophages from an M1 to an M2 phenotype [49].

The hydrophilic and hydrophobic characteristics of materials also exert a profound influence on macrophage adhesion, phenotype, and phagocytic activity. Surfaces modified to increase hydrophobicity promote macrophage adhesion and proliferation and suppress the pro-inflammatory response of M1 macrophages [120]. Interestingly for titanium materials, hydrophilic surfaces are associated with M2 polarization under both physiological and diabetic conditions [96,121,122].

Challenges and future perspectives

Adverse Immune Reactions Caused by Implanted Biomaterials

Macrophages play a dual role, not only participating in bone repair processes but also contributing significantly to foreign body reactions, a major challenge in the clinical application of biomaterials [123,124]. When phagocytosis of materials is frustrated, macrophages fuse to form FBGCs [124], which will release degradation mediators such as ROS and degradative enzymes, leading to an acidic environment at the biomaterial-tissue interface [124]. The degradation process may cause embrittlement, fragmentation, and damage to the biomaterial. Furthermore, degradation byproducts like lactic acid and carbon dioxide can exacerbate chronic inflammation [125]. In the late stages of the foreign body response, implanted biomaterials are encapsulated by a dense layer of avascular fibrotic tissue, which primarily forms due to myofibroblasts stimulated by TGF-β released from FBGCs [126]. The fibrous capsule isolates biomaterials from surrounding tissues, impeding their regulatory functions and causing discomfort and pain for patients [124]. These understandings of the intricate role of macrophages in foreign body reactions offer novel avenues to modulate biomaterial properties and mitigate adverse effects [127], especially in the context of diabetes mellitus.

Determining the Actual Effects of Biomaterials on Macrophages in Vivo

Though numerous studies have investigated the immunomodulatory effects of distinct biomaterials, drawing generalized conclusions remains challenging due to disparities in experimental conditions, including variations in cell sources, biomaterial concentrations, and culture duration [16]. Particularly, most of these experiments were conducted in vitro and over relatively short time frames, which may not fully align with the dynamic and variable conditions encountered by cells in vivo [128]. Furthermore, macrophages in vivo exhibit a spectrum of diverse phenotypes, which do not always correspond precisely to those induced by specific stimuli in vitro [128,129]. Meanwhile, human macrophage behavior is influenced by individual medical history, microbiome composition, and circadian rhythms, making accurate prediction of their responses challenging [130,131].

Another difficulty in the clinical application of macrophage-targeting biomaterials arises from disparities between mouse and human immune cells [132]. For instance, typical M1 and M2 markers in rodent models, such as iNOS and arginase 1, are not expressed in human macrophages [133], and the regulatory pathways controlling IL-10 and TGF-β1 expression differ between human and murine macrophages [133]. Another in vitro study observed that IL-4 and IL-13 upregulated the expression of IL-10 only in murine macrophages, while LPS and IFN-γ promoted vascular endothelial growth factor A (VEGFA) secretion merely from human macrophages [134,135]. Besides, macrophages from different origins may exhibit varying responses to identical physical cues. When cultured on a stiff substrate, human macrophages exhibited a greater increase in elasticity compared to RAW264.7 macrophages [136]. This discrepancy likely results from the stronger mechanical loading experienced by human macrophages in vivo, rendering them more sensitive to physical cues than RAW264.7 macrophages [137]. Despite considerable advancements in developing humanized mice with functional human immune systems, the high cost restricts their widespread application in experimental studies [138]. Hence, this issue remains to be further investigated.

The interaction between biomaterials, macrophages, and the skeletal system

In the past decades, extensive evidence has investigated the interplay between biomaterials, the skeletal system, and the immune system [22,139,140]. These systems dynamically modify their properties in a reciprocal manner, creating a feedback loop that eventually achieves equilibrium [141]. On this issue, further research is imperative to unravel the impact of the ever-changing microenvironment surrounding biomaterials on immune responses and osteogenesis processes. Moreover, understanding how immune cell behavior, particularly that of macrophages and stem cells, influences the properties and efficacy of biomaterials will yield precise guidelines and promising directions for designing and modifying biomaterials to treat diabetic bone defects.

Besides, while M2a macrophages are widely recognized as pivotal in tissue repair processes, the roles and temporal behaviors of other M2 subtypes remain to be clearly defined. Some studies have suggested that IL-10-stimulated M2c macrophages exhibit heightened activity during the early stages of tissue regeneration and may contribute to angiogenesis [142-144]. To advance our understanding, comprehensive investigations employing appropriate M1 and M2 markers, along with relevant gene analyses using diverse analytical methods as well as high-throughput analysis platforms, can provide critical insights into the interactions between different macrophage subtypes and biomaterials in both in vitro and in vivo settings, under physiological or pathological conditions [145].

Multidisciplinary integration

In recent years, significant strides have been made across diverse interdisciplinary domains pertaining to biomaterial research, significantly propelling the advancement and practical implementation of biomaterials for bone regeneration. More recently, machine learning and artificial intelligence have exhibited unique advantages in predicting interactions between macrophages and implants. For instance, Rostam et al. conducted a study involving a polymer library, leveraging machine learning techniques to establish connections between chemical descriptors of polymer structures and markers indicative of macrophage inflammatory responses [146]. Their findings highlighted a robust correlation between macrophage behavior and specific chemical features such as alkoxy groups and methacrylamide molecular fragments. Fostering greater multidisciplinary integration proves favorable in elucidating the underlying mechanisms governing macrophage behavior within biomaterial-based strategies for diabetic bone repair.

Conclusions

Characterized by high glucose and chronic inflammation, diabetes mellitus is one of the major metabolic diseases threatening global human health. Due to the complex and dynamic microenvironment in hyperglycemia conditions, treatment strategies for diabetes bone diseases require to be highly precise and effective, in regard to which biomaterials possess unique advantages by providing structural support for defect sites and serving as delivery platforms for drugs, bioactive molecules, and cells. Besides, as macrophages play a pivotal role in both the pathogenesis and repair of diabetic bone defects by influencing osteoimmune environments, numerous biomaterials have been designed with a macrophage-targeting approach.

These designs involve the controlled release of regulatory components and modulation of physicochemical properties, aiming to achieve sequential activation and maintenance of M1 and M2 phenotypes, enhanced M2/M1 ratio, and increased macrophage retention at defect sites, thereby enhancing bone regeneration in hyperglycemia. Despite substantial progress, overcoming adverse immune reactions caused by implanted biomaterials remains a challenge, necessitating a deeper understanding of interactions between biomaterials, the immune system, and the skeletal system in vivo. Furthermore, research on fabrication and modification technologies is necessary to regulate macrophage behaviors and functions more accurately and efficiently for bone regeneration in diabetes.

Disclosures

Author Contributions

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Jianru Yi

Acquisition, analysis, or interpretation of data:  Jianru Yi, Yiyan Yang, Zhihe Zhao, Xiaoli He

Critical review of the manuscript for important intellectual content:  Jianru Yi, Zhihe Zhao

Drafting of the manuscript:  Yiyan Yang, Xiaoli He
==== Refs
References

1 IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 Diabetes Res Clin Pract Sun H Saeedi P Karuranga S 109119 183 2022 34879977
2 Associations of new-onset atrial fibrillation with risks of cardiovascular disease, chronic kidney disease, and mortality among patients with type 2 diabetes Diabetes Care Geng T Wang Y Lu Q 2422 2429 45 2022 35984477
3 Diabetes mellitus and bone metabolism Exp Clin Endocrinol Diabetes Kasperk C Georgescu C Nawroth P 213 217 125 2017 28073133
4 Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study J Bone Miner Res Samelson EJ Demissie S Cupples LA 54 62 33 2018 28929525
5 Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus Cytokine Growth Factor Rev Shahen VA Gerbaix M Koeppenkastrop S 109 118 55 2020 32354674
6 Mechanisms of diabetes mellitus-induced bone fragility Nat Rev Endocrinol Napoli N Chandran M Pierroz DD Abrahamsen B Schwartz AV Ferrari SL 208 219 13 2017 27658727
7 Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia Front Endocrinol (Lausanne) Luo M Zhao Z Yi J 1150068 14 2023 37415664
8 Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways J Cell Biochem Botolin S McCabe LR 411 424 99 2006 16619259
9 Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus Nat Rev Endocrinol Khosla S Samakkarnthai P Monroe DG Farr JN 685 697 17 2021 34518671
10 Dysfunction of macrophages leads to diabetic bone regeneration deficiency Front Immunol Shen Y Zhang Y Zhou Z 990457 13 2022 36311779
11 Regulating macrophage polarization in high glucose microenvironment using lithium-modified bioglass-hydrogel for diabetic bone regeneration Adv Healthc Mater Wu Z Bai J Ge G 0 11 2022
12 Targeting RORα in macrophages to boost diabetic bone regeneration Cell Prolif Shen Y Tang Q Wang J 0 56 2023
13 Adrenomedullin 2 improves bone regeneration in type 1 diabetic rats by restoring imbalanced macrophage polarization and impaired osteogenesis Stem Cell Res Ther Wang F Kong L Wang W 288 12 2021 33985585
14 Advances in material-based strategies for diabetic bone regeneration Stem Cells Transl Med Li Z Yue M Zhou Y 243 254 13 2024 38134964
15 Design and application of biomaterials to regulate microenvironment for bone regeneration Biomaterials Effect on the Bone Microenvironment: Fabrication, Regeneration, and Clinical Applications Wang X Jiang Y 75 107 Weinheim, Germany Wiley‐VCH GmbH 2023
16 From hurdle to springboard: the macrophage as target in biomaterial-based bone regeneration strategies Bone Kim YH Oreffo RO Dawson JI 116389 159 2022 35301163
17 Macrophage plasticity and polarization: in vivo veritas J Clin Invest Sica A Mantovani A 787 795 122 2012 22378047
18 The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression Prog Neuropsychopharmacol Biol Psychiatry Kim YK Na KS Myint AM Leonard BE 277 284 64 2016 26111720
19 Macrophages modulate the viability and growth of human mesenchymal stem cells J Cell Biochem Freytes DO Kang JW Marcos-Campos I Vunjak-Novakovic G 220 229 114 2013 22903635
20 Macrophages in bone homeostasis Curr Stem Cell Res Ther Kong L Wang Y Smith W Hao D 474 481 14 2019 30767753
21 Mesenchymal stem cell-macrophage crosstalk and bone healing Biomaterials Pajarinen J Lin T Gibon E 80 89 196 2019 29329642
22 Modulating macrophage activities to promote endogenous bone regeneration: biological mechanisms and engineering approaches Bioact Mater Niu Y Wang Z Shi Y Dong L Wang C 244 261 6 2021 32913932
23 Mesenchymal stem cell proliferation and mineralization but not osteogenic differentiation are strongly affected by extracellular pH J Craniomaxillofac Surg Fliefel R Popov C Tröltzsch M Kühnisch J Ehrenfeld M Otto S 715 724 44 2016 27085985
24 The cytokines and micro-environment of fracture haematoma: current evidence J Tissue Eng Regen Med Walters G Pountos I Giannoudis PV 0 77 12 2018
25 The multifaceted roles of macrophages in bone regeneration: a story of polarization, activation and time Acta Biomater Schlundt C Fischer H Bucher CH Rendenbach C Duda GN Schmidt-Bleek K 46 57 133 2021 33974949
26 The role of macrophage phenotype in vascularization of tissue engineering scaffolds Biomaterials Spiller KL Anfang RR Spiller KJ Ng J Nakazawa KR Daulton JW Vunjak-Novakovic G 4477 4488 35 2014 24589361
27 Induced migration of endothelial cells into 3D scaffolds by chemoattractants secreted by pro-inflammatory macrophages in situ Regen Biomater Li X Dai Y Shen T Gao C 139 148 4 2017 28596912
28 Macrophages of diverse phenotypes drive vascularization of engineered tissues Sci Adv Graney PL Ben-Shaul S Landau S 0 6 2020
29 The bone remodelling cycle Ann Clin Biochem Kenkre JS Bassett J 308 327 55 2018 29368538
30 Co-culture of bone marrow stem cells and macrophages indicates intermediate mechanism between local inflammation and innate immune system in diabetic periodontitis Exp Ther Med Wang J Li H Li B Gong Q Chen X Wang Q 567 572 12 2016 27446245
31 Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro Inflammation Taichman RS Hauschka PV 587 601 16 1992 1459694
32 TNF‑α and RANKL promote osteoclastogenesis by upregulating RANK via the NF‑κB pathway Mol Med Rep Luo G Li F Li X Wang ZG Zhang B 6605 6611 17 2018 29512766
33 IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro Cell Physiol Biochem Wu Q Zhou X Huang D Ji Y Kang F 1360 1369 41 2017 28278513
34 Macrophage effects on mesenchymal stem cell osteogenesis in a three-dimensional in vitro bone model Tissue Eng Part A Romero-López M Li Z Rhee C 1099 1111 26 2020 32312178
35 Macrophage type modulates osteogenic differentiation of adipose tissue MSCs Cell Tissue Res Zhang Y Böse T Unger RE Jansen JA Kirkpatrick CJ van den Beucken JJ 273 286 369 2017 28361303
36 Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages Exp Mol Med Cho DI Kim MR Jeong HY 0 46 2014
37 In vitro characterization of macrophage interaction with mesenchymal stromal cell-hyaluronan hydrogel constructs J Biomed Mater Res A King SN Hanson SE Chen X Kim J Hematti P Thibeault SL 890 902 102 2014 23564555
38 Mechanisms of organ injury and repair by macrophages Annu Rev Physiol Vannella KM Wynn TA 593 617 79 2017 27959618
39 Reactive oxygen species (ROS) in macrophage activation and function in diabetes Immunobiology Rendra E Riabov V Mossel DM Sevastyanova T Harmsen MC Kzhyshkowska J 242 253 224 2019 30739804
40 Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging Int J Oral Sci Wang Q Nie L Zhao P Zhou X Ding Y Chen Q Wang Q 11 13 2021 33762572
41 Pro-inflammatory polarization primes macrophages to transition into a distinct M2-like phenotype in response to IL-4 J Leukoc Biol O'Brien EM Spiller KL 989 1000 111 2022 34643290
42 Macrophage-derived TGF-β and VEGF promote the progression of trauma-induced heterotopic ossification Inflammation Tu B Li J Sun Z Zhang T Liu H Yuan F Fan C 202 216 46 2023 35986177
43 Sequential drug delivery to modulate macrophage behavior and enhance implant integration Adv Drug Deliv Rev O'Brien EM Risser GE Spiller KL 85 94 149-150 2019 31103451
44 Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model J Bone Miner Res Alexander KA Chang MK Maylin ER 1517 1532 26 2011 21305607
45 Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification Am J Pathol Raggatt LJ Wullschleger ME Alexander KA 3192 3204 184 2014 25285719
46 Biomaterial-assisted macrophage cell therapy for regenerative medicine Adv Drug Deliv Rev Sung S Steele LA Risser GE Spiller KL 114979 199 2023 37394101
47 Mechanobiologically optimized 3D titanium-mesh scaffolds enhance bone regeneration in critical segmental defects in sheep Sci Transl Med Pobloth AM Checa S Razi H 8828 10 2018
48 Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: a review Biomaterials Wang X Xu S Zhou S 127 141 83 2016 26773669
49 Electrical stimulation of piezoelectric BaTiO3 coated Ti6Al4V scaffolds promotes anti-inflammatory polarization of macrophages and bone repair via MAPK/JNK inhibition and OXPHOS activation Biomaterials Wu H Dong H Tang Z 121990 293 2023 36586147
50 Aspirin/PLGA coated 3D-printed Ti-6Al-4V alloy modulate macrophage polarization to enhance osteoblast differentiation and osseointegration J Mater Sci Mater Med You Y Wang W Li Y 73 33 2022 36209337
51 Recent developments in the reduction of oxidative stress through antioxidant polymeric formulations Pharmaceutics Zafar MS Quarta A Marradi M Ragusa A 505 11 2019 31581497
52 Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component Biomaterials Brown BN Valentin JE Stewart-Akers AM McCabe GP Badylak SF 1482 1491 30 2009 19121538
53 Consequences of ineffective decellularization of biologic scaffolds on the host response Biomaterials Keane TJ Londono R Turner NJ Badylak SF 1771 1781 33 2012 22137126
54 Biodegradable polymers in biomedical applications: a review-developments, perspectives and future challenges Int J Mol Sci Kurowiak J Klekiel T Będziński R 16952 24 2023 38069272
55 Alginate-based biomaterial-mediated regulation of macrophages in bone tissue engineering Int J Biol Macromol Li Y Xu Z Wang J Pei X Chen J Wan Q 123246 230 2023 36649862
56 Anti-oxidant and immune-modulatory properties of sulfated alginate derivatives on human chondrocytes and macrophages Biomater Sci Kerschenmeyer A Arlov Ø Malheiro V 1756 1765 5 2017 28643827
57 Preparation, characterization and macrophage-stimulating activity of polyguluronate nanoliposomes Int J Biol Macromol Yang P Bi D Lu K 478 485 213 2022 35643158
58 Long‐term recruitment of endogenous M2 macrophages by platelet lysate‐rich plasma macroporous hydrogel scaffold for articular cartilage defect repair Adv Healthc Mater Pan X Yuan S Xun X 0 11 2022
59 A new class of biological materials: cell membrane-derived hydrogel scaffolds Biomaterials Fan Z Deng J Li PY 244 254 197 2019 30669015
60 Materials design for bone-tissue engineering Nature Rev Mat Koons GL Diba M Mikos AG 584 603 5 2020 https://www.nature.com/articles/s41578-020-0204-2
61 Biomimetic Medical Materials: From Nanotechnology to 3D Bioprinting Noh I Singapore Springer 2018 https://link.springer.com/book/10.1007/978-981-13-0445-3
62 Bioactive poly(octanediol-citrate-polyglycol) accelerates skin regeneration through M2 polarization immunomodulating and early angiogenesis Adv Healthc Mater Xie C Luo M Chen M Wang M Qu X Lei B 0 11 2022
63 A study focused on macrophages modulation induced by the polymeric electrospun matrices (EL-Ms) for application in tissue regeneration: In vitro proof of concept Int J Pharm Pisani S Dorati R Genta I Benazzo M Conti B Prina Mello A 120712 603 2021 34015377
64 Bioactive polymeric scaffolds for osteogenic repair and bone regenerative medicine Med Res Rev Amiryaghoubi N Fathi M Pesyan NN Samiei M Barar J Omidi Y 1833 1870 40 2020 32301138
65 Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: a review Int J Biol Macromol Kuang Y Zhai J Xiao Q Zhao S Li C 457 473 193 2021 34710474
66 Poly (d, l-lactide)(PDLLA) foams with TiO 2 nanoparticles and PDLLA/TiO 2-Bioglass® foam composites for tissue engineering scaffolds J Mat Sci Boccaccini AR Blaker JJ Maquet V Chung W Jérôme R Nazhat SN 3999 4008 41 2006 https://link.springer.com/article/10.1007/s10853-006-7575-7
67 Construction and application of base-stable MOFs: a critical review Chem Soc Rev Wang K Li Y Xie LH Li X Li JR 6417 6441 51 2022 35702993
68 On the road to smart biomaterials for bone research: definitions, concepts, advances, and outlook Bone Res Montoya C Du Y Gianforcaro AL Orrego S Yang M Lelkes PI 12 9 2021 33574225
69 A logic‐based diagnostic and therapeutic hydrogel with multistimuli responsiveness to orchestrate diabetic bone regeneration Adv Mater Li D Chen K Tang H 0 34 2022
70 Locally controlled delivery of TNFα antibody from a novel glucose-sensitive scaffold enhances alveolar bone healing in diabetic conditions J Control Release Wang Q Li H Xiao Y 232 242 206 2015 25796348
71 Magnesium-organic framework-based stimuli-responsive systems that optimize the bone microenvironment for enhanced bone regeneration Chem Engineer J Zheng Z Chen Y Guo B 125241 396 2020
72 Magnetic manipulation of reversible nanocaging controls in vivo adhesion and polarization of macrophages ACS Nano Kang H Jung HJ Kim SK 5978 5994 12 2018 29767957
73 Bioprinting au natural: the biologics of bioinks Biomolecules Willson K Atala A Yoo JJ 1593 11 2021 34827591
74 Three-dimensional bioprinting of multicell-laden scaffolds containing bone morphogenic protein-4 for promoting M2 macrophage polarization and accelerating bone defect repair in diabetes mellitus Bioact Mater Sun X Ma Z Zhao X 757 769 6 2021 33024897
75 Spatiotemporal immunomodulation using biomimetic scaffold promotes endochondral ossification‐mediated bone healing Adv Sci (Weinh) Liu Y Yang Z Wang L 0 8 2021
76 Reparative inflammation takes charge of tissue regeneration Nature Karin M Clevers H 307 315 529 2016 26791721
77 Induction of M2-type macrophage differentiation for bone defect repair via an interpenetration network hydrogel with a go-based controlled release system Adv Healthc Mater Zou M Sun J Xiang Z 0 10 2021
78 Development of an accurate and proactive immunomodulatory strategy to improve bone substitute material-mediated osteogenesis and angiogenesis Theranostics Zheng ZW Chen YH Wu DY 5482 5500 8 2018 30555559
79 Immunomodulatory ECM-like microspheres for accelerated bone regeneration in diabetes mellitus ACS Appl Mater Interfaces Hu Z Ma C Rong X Zou S Liu X 2377 2390 10 2018 29280610
80 Abnormal macrophage polarization impedes the healing of diabetes-associated tooth sockets Bone Shen X Shen X Li B 115618 143 2021 32858254
81 Physically cross-linked DNA hydrogel-based sustained cytokine delivery for in situ diabetic alveolar bone rebuilding ACS Appl Mater Interfaces Li W Wang C Wang Z 25173 25182 14 2022 35638566
82 Sustained delivery of IL-10 by self-assembling peptide hydrogel to reprogram macrophages and promote diabetic alveolar bone defect healing Dent Mater Wang C Li T Zeng X 418 429 39 2023 36931990
83 Bilayered laponite/alginate-poly(acrylamide) composite hydrogel for osteochondral injuries enhances macrophage polarization: an in vivo study Biomater Adv Saygili E Saglam-Metiner P Cakmak B 112721 134 2022 35581061
84 The immunomodulatory role of BMP-2 on macrophages to accelerate osteogenesis Tissue Eng Part A Wei F Zhou Y Wang J Liu C Xiao Y 584 594 24 2018 28726579
85 High proportion strontium-doped micro-arc oxidation coatings enhance early osseointegration of titanium in osteoporosis by anti-oxidative stress pathway Bioact Mater Shen X Fang K Ru Yie KH 405 419 10 2022 34901556
86 HA/MgO nanocrystal-based hybrid hydrogel with high mechanical strength and osteoinductive potential for bone reconstruction in diabetic rats J Mater Chem B Chen R Chen HB Xue PP 1107 1122 9 2021 33427267
87 The impact of sitagliptin on macrophage polarity and angiogenesis in the osteointegration of titanium implants in type 2 diabetes Biomed Pharmacother Xiang G Huang X Wang T 110078 126 2020 32172067
88 In situ regulation of macrophage polarization to enhance osseointegration under diabetic conditions using injectable silk/sitagliptin gel scaffolds Adv Sci (Weinh) Xiang G Liu K Wang T 2002328 8 2021 33552858
89 Sitagliptin attenuates Porphyromonas gingivalis virulence and inflammatory response in macrophage on titanium Arch Oral Biol Tang W Du M Zhang S Jiang H 105659 149 2023 36871330
90 Macrophage phenotype switch by sequential action of immunomodulatory cytokines from hydrogel layers on titania nanotubes Colloids Surf B Biointerfaces Chen J Li M Yang C Yin X Duan K Wang J Feng B 336 345 163 2018 29331905
91 Self-assembling multidomain peptides tailor biological responses through biphasic release Biomaterials Kumar VA Taylor NL Shi S Wickremasinghe NC D'Souza RN Hartgerink JD 71 78 52 2015 25818414
92 Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes Diabetes Gallagher KA Joshi A Carson WF 1420 1430 64 2015 25368099
93 Material stiffness influences the polarization state, function and migration mode of macrophages Acta Biomater Sridharan R Cavanagh B Cameron AR Kelly DJ O'Brien FJ 47 59 89 2019 30826478
94 PCL/EUG scaffolds with tunable stiffness can regulate macrophage secretion behavior Prog Biophys Mol Biol Xue YZ Niu YM Tang B Wang CM 4 11 148 2019 31226307
95 Substrate stiffness modulates bone marrow-derived macrophage polarization through NF-κB signaling pathway Bioact Mater Chen M Zhang Y Zhou P 880 890 5 2020 32637751
96 Re-establishment of macrophage homeostasis by titanium surface modification in type II diabetes promotes osseous healing Biomaterials Lee RS Hamlet SM Moon HJ Ivanovski S 120464 267 2021 33130322
97 Designer micro-/nanocrumpled MXene multilayer coatings accelerate osteogenesis and regulate macrophage polarization ACS Appl Mater Interfaces Asadi Tokmedash M Min J 21415 21426 16 2024 38445580
98 Improved implant osseointegration of a nanostructured titanium surface via mediation of macrophage polarization Biomaterials Ma QL Zhao LZ Liu RR 9853 9867 35 2014 25201737
99 Micro-and nanopatterned topographical cues for regulating macrophage cell shape and phenotype ACS Appl Mater Interfaces Luu TU Gott SC Woo BW Rao MP Liu WF 28665 28672 7 2015 26605491
100 Modulation of macrophage phenotype by cell shape Proc Natl Acad Sci U S A McWhorter FY Wang T Nguyen P Chung T Liu WF 17253 17258 110 2013 24101477
101 Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds Biomaterials Garg K Pullen NA Oskeritzian CA Ryan JJ Bowlin GL 4439 4451 34 2013 23515178
102 Nanoporous microstructures mediate osteogenesis by modulating the osteo-immune response of macrophages Nanoscale Chen Z Ni S Han S 706 718 9 2017 27959374
103 Nanoscaled biphasic calcium phosphate modulates osteogenesis and attenuates LPS-induced inflammation Front Bioeng Biotechnol Su YC Phan TT Wang TW Chang SH Lin FH Hsu TS Lin LY 1236429 11 2023 38094898
104 Orthopaedic implant materials drive M1 macrophage polarization in a spleen tyrosine kinase- and mitogen-activated protein kinase-dependent manner Acta Biomater Mahon OR O'Hanlon S Cunningham CC 426 435 65 2018 29104084
105 Influences of size and surface coating of gold nanoparticles on inflammatory activation of macrophages Colloids Surf B Biointerfaces Chen X Gao C 372 380 160 2017 28963958
106 Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro Int J Nanomedicine Bancos S Stevens DL Tyner KM 183 206 10 2015
107 Hydroxyapatite particle shape and size influence msc osteogenesis by directing the macrophage phenotype in collagen-hydroxyapatite scaffolds ACS Appl Bio Mater Sridharan R Genoud KJ Kelly DJ O'Brien FJ 7562 7574 3 2020
108 The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation Sci Rep Lebre F Sridharan R Sawkins MJ Kelly DJ O'Brien FJ Lavelle EC 2922 7 2017 28592868
109 Effects of nanocrystalline hydroxyapatites on macrophage polarization J Mater Chem B Linares J Fernández AB Feito MJ 1951 1959 4 2016 32263072
110 Role of macrophage (M1 and M2) in titanium-dioxide nanoparticle-induced oxidative stress and inflammatory response in rat Appl Biochem Biotechnol Kumar S Meena R Paulraj R 1257 1275 180 2016 27318710
111 High and low molecular weight hyaluronic acid differentially influence macrophage activation ACS Biomater Sci Eng Rayahin JE Buhrman JS Zhang Y Koh TJ Gemeinhart RA 481 493 1 2015 26280020
112 Surface plasma functionalization influences macrophage behavior on carbon nanowalls Mater Sci Eng C Mater Biol Appl Ion R Vizireanu S Stancu CE Luculescu C Cimpean A Dinescu G 118 125 48 2015 25579904
113 Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction Nat Immunol Shi CS Shenderov K Huang NN 255 263 13 2012 22286270
114 Tuning chemistry and topography of nanoengineered surfaces to manipulate immune response for bone regeneration applications ACS Nano Chen Z Bachhuka A Han S 4494 4506 11 2017 28414902
115 Polydopamine-mediated graphene oxide and nanohydroxyapatite-incorporated conductive scaffold with an immunomodulatory ability accelerates periodontal bone regeneration in diabetes Bioact Mater Li Y Yang L Hou Y 213 227 18 2022 35387166
116 Bone bioelectricity and bone-cell response to electrical stimulation: a review Crit Rev Biomed Eng deVet T Jhirad A Pravato L Wohl GR 1 19 49 2021
117 Piezoelectric signals in vascularized bone regeneration Biomolecules D'Alessandro D Ricci C Milazzo M 1731 11 2021 34827729
118 Restoration of electrical microenvironment enhances bone regeneration under diabetic conditions by modulating macrophage polarization Bioact Mater Dai X Heng BC Bai Y 2029 2038 6 2021 33474514
119 Tuning the surface potential to reprogram immune microenvironment for bone regeneration Biomaterials Li M Chu X Wang D 121408 282 2022 35189460
120 Alter macrophage adhesion and modulate their response on hydrophobically modified hydrogels Biochem Engineer J Xu Z Hwang DG Bartlett MD Jiang S Bratlie KM 107821 165 2021 https://doi.org/10.1016/j.bej.2020.107821
121 Hydrophilic titanium surface-induced macrophage modulation promotes pro-osteogenic signalling Clin Oral Implants Res Hamlet SM Lee RS Moon HJ Alfarsi MA Ivanovski S 1085 1096 30 2019 31397920
122 The influence of titanium surface characteristics on macrophage phenotype polarization during osseous healing in type I diabetic rats: a pilot study Clin Oral Implants Res Lee RS Hamlet SM Ivanovski S 0 68 28 2017
123 Promoting musculoskeletal system soft tissue regeneration by biomaterial-mediated modulation of macrophage polarization Bioact Mater Ye J Xie C Wang C 4096 4109 6 2021 33997496
124 Foreign body reaction to biomaterials Semin Immunol Anderson JM Rodriguez A Chang DT 86 100 20 2008 18162407
125 Biodegradable Polymers. Principles of Tissue Engineering (Third Edition) Pachence JM Bohrer MP Kohn J: Chapter Twenty-Three 323 339 Burlington Academic Press 2007
126 Mechanisms of foreign body giant cell formation in response to implantable biomaterials Polymers (Basel) Eslami-Kaliji F Hedayat Nia N Lakey JR Smink AM Mohammadi M 1313 15 2023 36904554
127 Macrophage and fibroblast interactions in biomaterial‐mediated fibrosis Adv Healthc Mater Witherel CE Abebayehu D Barker TH Spiller KL 0 8 2019
128 A surprisingly poor correlation between in vitro and in vivo testing of biomaterials for bone regeneration: results of a multicentre analysis Eur Cell Mater Hulsart-Billström G Dawson JI Hofmann S 312 322 31 2016 https://www.ecmjournal.org/papers/vol031/vol031a20.php 27215739
129 Interleukin-36γ-producing macrophages drive IL-17-mediated fibrosis Sci Immunol Sommerfeld SD Cherry C Schwab RM 4783 4 2019
130 A circadian clock in macrophages controls inflammatory immune responses Proc Natl Acad Sci U S A Keller M Mazuch J Abraham U 21407 21412 106 2009 19955445
131 Making mouse models that reflect human immune responses Trends Immunol Tao L Reese TA 181 193 38 2017 28161189
132 Genomic responses in mouse models poorly mimic human inflammatory diseases Proc Natl Acad Sci U S A Seok J Warren HS Cuenca AG 3507 3512 110 2013 23401516
133 Differential gene expression in human, murine, and cell line-derived macrophages upon polarization Exp Cell Res Spiller KL Wrona EA Romero-Torres S 1 13 347 2016 26500109
134 Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages Int Immunopharmacol Malaguarnera L Imbesi R Di Rosa M Scuto A Castrogiovanni P Messina A Sanfilippo S 1458 1469 5 2005 15953572
135 Differential responses of human monocytes and macrophages to IL‐4 and IL‐13 J Leukoc Bio Hart PH Bonder CS Balogh J Dickensheets HL Donnelly RP Finlay‐Jones JJ 575 578 66 1999 https://pubmed.ncbi.nlm.nih.gov/10534111/ 10534111
136 Cell elasticity determines macrophage function PLoS One Patel NR Bole M Chen C 0 7 2012
137 Physical and mechanical regulation of macrophage phenotype and function Cell Mol Life Sci McWhorter FY Davis CT Liu WF 1303 1316 72 2015 25504084
138 Humanized mouse models of clinical disease Annu Rev Pathol Walsh NC Kenney LL Jangalwe S Aryee KE Greiner DL Brehm MA Shultz LD 187 215 12 2017 27959627
139 Immunomodulatory strategies for bone regeneration: a review from the perspective of disease types Biomaterials Su N Villicana C Yang F 121604 286 2022 35667249
140 The role of the immune microenvironment in bone regeneration Int J Med Sci Yang N Liu Y 3697 3707 18 2021 34790042
141 Tissue engineering meets immunoengineering: prospective on personalized in situ tissue engineering strategies Curr Op Biomed Engineer Smits AI Bouten CV 17 26 6 2018
142 Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing Immunobiology Lurier EB Dalton D Dampier W 847 856 222 2017 28318799
143 Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction J Immunol Zizzo G Hilliard BA Monestier M Cohen PL 3508 3520 189 2012 22942426
144 Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo Angiogenesis Jetten N Verbruggen S Gijbels MJ Post MJ De Winther MP Donners MM 109 118 17 2014 24013945
145 Omics technologies for high-throughput-screening of cell-biomaterial interactions Mol Omics Sari B Isik M Eylem CC 591 615 18 2022 35723504
146 Immune-instructive polymers control macrophage phenotype and modulate the foreign body response in vivo Matter Rostam HM Fisher LE Hook AL 1564 1581 2 2020
